Testosterone Cypionate is a drug owned by Slayback Pharma Llc. It is protected by 2 US drug patents filed from 2022 to 2023 out of which none have expired yet. Based on its patents and exclusivities, its generic launch date is estimated to be Mar 25, 2039. Details of Testosterone Cypionate's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US11642355 | Pharmaceutical compositions of testosterone |
Mar, 2039
(14 years from now) | Active |
| US11311554 | Pharmaceutical compositions of testosterone |
Mar, 2039
(14 years from now) | Active |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Testosterone Cypionate's patents.
Latest Legal Activities on Testosterone Cypionate's Patents
Given below is the list of recent legal activities going on the following patents of Testosterone Cypionate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 19 Jan, 2024 | US11642355 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 19 Jan, 2024 | US11311554 |
| Electronic Review Critical | 09 May, 2023 | US11642355 |
| Patent eGrant Notification | 09 May, 2023 | US11642355 |
| Recordation of Patent eGrant | 09 May, 2023 | US11642355 |
| Mail Patent eGrant Notification | 09 May, 2023 | US11642355 |
| Recordation of Patent Grant Mailed Critical | 09 May, 2023 | US11642355 |
| Patent Issue Date Used in PTA Calculation Critical | 09 May, 2023 | US11642355 |
| Email Notification Critical | 09 May, 2023 | US11642355 |
| Email Notification Critical | 20 Apr, 2023 | US11642355 |
US patents provide insights into the exclusivity only within the United States, but Testosterone Cypionate is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Testosterone Cypionate's family patents as well as insights into ongoing legal events on those patents.
Testosterone Cypionate's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Testosterone Cypionate's generic launch date based on the expiry of its last outstanding patent is estimated to be Mar 25, 2039 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Testosterone Cypionate Generics:
Testosterone Cypionate is the generic name for the brand Testosterone Cypionate. 14 different companies have already filed for the generic of Testosterone Cypionate, with Pfizer having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Testosterone Cypionate's generic
About Testosterone Cypionate
Testosterone Cypionate is a drug owned by Slayback Pharma Llc. Testosterone Cypionate uses Testosterone Cypionate as an active ingredient. Testosterone Cypionate was launched by Slayback Pharma Llc in 2022.
Approval Date:
Testosterone Cypionate was approved by FDA for market use on 02 June, 2022.
Active Ingredient:
Testosterone Cypionate uses Testosterone Cypionate as the active ingredient. Check out other Drugs and Companies using Testosterone Cypionate ingredient
Dosage:
Testosterone Cypionate is available in solution form for intramuscular use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 200MG/ML (200MG/ML) | SOLUTION | Discontinued | INTRAMUSCULAR |